Identification of Myfembree:
No description |
Search images on Google Product Monograph
Active Ingredients:
- relugolix, 40 MG
- estradiol, 1 MG
- norethindrone acetate, 0.5 MG
DIN: 02541742
Dosage Form(s): TABLET
Route(s) of Administration: ORAL
Schedule: Prescription
Company: SUMITOMO PHARMA SWITZERLAND GMBH
ATC:
- H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, WHO, Wiki)
- H01C - HYPOTHALAMIC HORMONES (ATC, WHO)
- H01CC - Anti-gonadotropin-releasing hormones (ATC, WHO)
- H01CC54 - RELUGOLIX, ESTRADIOL AND NORETHISTERONE (WHO)